Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention

The Canadian Journal of Cardiology
Jason G AndradeSean Connors

Abstract

Real-world data on patients' and physicians' values related to the use of oral anticoagulant (OAC) therapy for stroke prevention in patients with nonvalvular atrial fibrillation are currently lacking. We sought to assess the values, preferences, and experience of patients who receive OAC therapy, and of physicians who prescribe OAC therapy. A national survey of randomly selected patients (n = 266) and physicians (n = 178) was conducted between May and September 2014. Each was asked to evaluate the importance of individual OAC attributes and identify which of 2 medication profiles they would prefer (individual attributes were progressively modified to determine which were the most valued and/or influenced treatment choice). Medication adherence and prescription practice was also assessed. The preferences of patients and physicians regarding OAC therapy differed but largely focused on characteristics related to safety and, to a lesser extent, efficacy. When based solely on the basis of the attribute profile (blinded to the specific agent), physicians were more likely to select apixaban (61%), whereas patients showed no significant preference among apixaban, rivaroxaban, and warfarin. Despite this, 49% of physicians spontaneously ...Continue Reading

References

Nov 4, 2005·The New England Journal of Medicine·Ronald J Campbell
Jan 1, 2010·The New England Journal of Medicine·Donald Stuart Houston, Ryan Zarychanski
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Dec 3, 2013·BMC Cardiovascular Disorders·Ameet BakhaiJose L Zamorano
Mar 22, 2014·Current Medical Research and Opinion·François LalibertéPatrick Lefebvre
Sep 30, 2014·The Canadian Journal of Cardiology·Atul VermaUNKNOWN CCS Atrial Fibrillation Guidelines Committee

❮ Previous
Next ❯

Citations

Oct 27, 2016·Journal of Managed Care & Specialty Pharmacy·Joshua D BrownJeffery C Talbert
Jun 28, 2017·Therapeutic Advances in Cardiovascular Disease·Alexander G G TurpieAntonio Ciaccia
Apr 26, 2018·Journal of Managed Care & Specialty Pharmacy·Clara L Rodriguez-BernalGabriel Sanfélix-Gimeno
Oct 24, 2018·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Ahmed El-BardissyAbdul Moqeeth Mohammed
Feb 7, 2019·The Annals of Pharmacotherapy·Peter S LoewenShahrzad Salmasi
Apr 9, 2020·Journal of Cardiovascular Pharmacology and Therapeutics·Arnaud PagèsBrigitte Sallerin
Apr 25, 2020·Journal of Comparative Effectiveness Research·Carmen Suárez FernándezFrancesc Formiga
Apr 24, 2020·Expert Review of Cardiovascular Therapy·Kannan SridharanKawther Mohamed Qader
Nov 12, 2016·Journal of Thrombosis and Thrombolysis·Zachary D HaleGeoffrey D Barnes
Sep 2, 2017·Expert Opinion on Drug Safety·Matthias Hammwöhner, Andreas Goette
Apr 5, 2020·BMC Health Services Research·Katherine H HoGillian Leng
Apr 7, 2017·International Journal of Stroke : Official Journal of the International Stroke Society·Joshua O CerasuoloLuciano A Sposato
Mar 18, 2017·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Sadık Volkan EmrenMehdi Zoghi
Jul 1, 2020·Journal of Thrombosis and Thrombolysis·Olga GavínJuan José Cerezo-Manchado
Jul 6, 2019·Journal of Thrombosis and Thrombolysis·Jack N WrightDaniel M Witt
Feb 16, 2017·Future Cardiology·Sarah MonagleVinai C Bhagirath
Oct 28, 2020·Journal of Pharmacy Practice·Rebekah M BenitezBethany A Kalich
Jan 2, 2021·The American Journal of Cardiology·Alan SugrueMalini Madhavan
Jan 1, 2021·European Heart Journal Supplements : Journal of the European Society of Cardiology·Matthias Hammwöhner, Andreas Goette
May 20, 2021·Patient Preference and Adherence·Kristina MedlinskieneDuncan Petty

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.